1,692 results on '"Bussiere, Jeanine"'
Search Results
2. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab
3. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine
4. Nonclinical Safety Evaluation of Drugs
5. Knockout, Genetic
6. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period
7. Reproductive toxicity of denosumab in cynomolgus monkeys
8. Assessment of menstrual cycle length in cynomolgus monkeys as a female fertility endpoint of a biopharmaceutical in a 6 month toxicity study
9. Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical Method
10. Threshold for Anaphylactoid Reaction to Polysorbate 80 in Canines
11. Polysorbate 80-Induced Anaphylactoid Reaction and the Effects on Cardiovascular Function: Dose Threshold and Species Comparison
12. Preclinical Safety Assessment Considerations in Vaccine Development
13. Adjuvant Effects on Morphine-Induced Suppression of Immune Responses to MN rgp120/HIV-1 in Mice
14. Mouse Strain Differences in in vivo and in vitro Immunosuppressive Effects of Opioids
15. An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners
16. Immunosuppressive Effects of Morphine on Immune Responses in Mice
17. Identification of safety margins for polysorbate 80 exposure in canines
18. A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R
19. Supplemental Material, sj-docx-4-ijt-10.1177_10915818211008175 - Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
20. Supplemental Material, sj-docx-3-ijt-10.1177_10915818211008175 - Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
21. Supplemental Material, sj-docx-2-ijt-10.1177_10915818211008175 - Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
22. Supplemental Material, sj-docx-5-ijt-10.1177_10915818211008175 - Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
23. Supplemental Material, sj-docx-1-ijt-10.1177_10915818211008175 - Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
24. Assessing migraine therapeutics
25. Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey
26. Protection of MN-rgpl20-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1
27. Supplemental Material, sj-docx-1-tpx-10.1177_0192623320966238 - Phosphatidylinositol 3-Kinase δ Inhibitor-Induced Immunomodulation and Secondary Opportunistic Infection in the Cynomolgus Monkey (Macaca fascicularis)
28. Nonclinical Safety Evaluation of Drugs
29. Phosphatidylinositol 3-Kinase δ Inhibitor-Induced Immunomodulation and Secondary Opportunistic Infection in the Cynomolgus Monkey (Macaca fascicularis)
30. Relevant Immune Tests across Different Species and Surrogate Models
31. Differentiation between Desired Immunomodulation and Potential Immunotoxicity
32. Survey results on the use of the tissue cross-reactivity immunohistochemistry assay
33. Safety Assessment Of Biotechnology-derived Therapeutic Drugs
34. Pulmonary Delivery of Anti-IgE
35. Preclinical Safety Assessment Considerations in Vaccine Development
36. Mouse Strain Differences in in vivo and in vitro Immunosuppressive Effects of Opioids
37. Adjuvant Effects on Morphine-Induced Suppression of Immune Responses to MN rgp120/HIV-1 in Mice
38. Safety and antitumor activity of recombinant soluble Apo2 ligand
39. The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash
40. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
41. The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash.
42. Immunogenicity and Immune-Related Adverse Drug Reactions
43. Process‐Related Impurities in Biopharmaceuticals
44. Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro
45. An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners
46. PDADMAC flocculation of Chinese hamster ovary cells: Enabling a centrifuge-less harvest process for monoclonal antibodies
47. General Toxicity Testing and Immunotoxicity Testing for Biopharmaceuticals
48. Placental Transfer of a Fully Human IgG2 Monoclonal Antibody in the Cynomolgus Monkey, Rat, and Rabbit: A Comparative Assessment from during Organogenesis to Late Gestation
49. Assessment of menstrual cycle length in cynomolgus monkeys as a female fertility endpoint of a biopharmaceutical in a 6month toxicity study
50. Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.